Special edition: Winning the race against anti-malarial drug resistance

Podcast: This Week in Global Development · Devex | Global Development

Opublikowano: 2026-10-22

The threat of antimalarial drug resistance is growing in Eastern and Southern Africa, where the malaria parasite is rapidly adapting to existing treatments. With WHO modeling showing that a full-blown resistance crisis could lead to nearly 16 million additional cases and 80,000 deaths annually, Dr. Martin Fitchet of Medicines for Malaria Venture and Joy Phumaphi of the African Leaders Malaria Alliance sit down with Devex’s Alan Robbins to discuss why proactive R&D funding must be treated as an immediate global health priority. This spotlight segment presented in partnership with Medicines for Malaria Venture explores next-generation pipeline solutions, in...